- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
短期的强势行情可能结束，投资者及时短线卖出、离场观望为宜。
- 中期趋势：
正处于反弹阶段。
- 长期趋势：
已有253家主力机构披露2025-12-31报告期持股数据，持仓量总计6.80亿股，占流通A股43.22%
- 波段诊断：
-
技术面诊股
诊断结果：6.3技术面打败了84%的股票
技术面评分前10的股票
近期的平均成本为13.41元。空头行情中，目前正处于反弹阶段，投资者可适当关注。
平均成本
近期的平均成本为13.41元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"13.41","date":1784188486,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑赢大盘，跑赢行业平均水平。
[{"date":"2026.07.17","stock":"-3.51","trade":"-7.01","ind":"-5.40"},{"date":"2026.07.16","stock":"2.55","trade":"0.36","ind":"-1.97"},{"date":"2026.07.15","stock":"1.68","trade":"2.67","ind":"-0.97"},{"date":"2026.07.14","stock":"1.39","trade":"2.74","ind":"2.77"},{"date":"2026.07.13","stock":"0.94","trade":"-1.36","ind":"-3.48"},{"date":"2026.07.10","stock":"1.35","trade":"3.33","ind":"-2.29"},{"date":"2026.07.09","stock":"-0.94","trade":"0.10","ind":"3.07"},{"date":"2026.07.08","stock":"0.55","trade":"-1.54","ind":"-1.87"},{"date":"2026.07.07","stock":"-3.21","trade":"-4.28","ind":"-1.24"},{"date":"2026.07.06","stock":"1.71","trade":"1.41","ind":"-1.16"},{"date":"2026.07.03","stock":"1.10","trade":"1.88","ind":"0.64"},{"date":"2026.07.02","stock":"1.11","trade":"-0.24","ind":"-3.85"},{"date":"2026.07.01","stock":"3.36","trade":"4.33","ind":"-0.53"},{"date":"2026.06.30","stock":"-3.86","trade":"-0.54","ind":"2.48"},{"date":"2026.06.29","stock":"4.62","trade":"7.43","ind":"0.19"},{"date":"2026.06.26","stock":"-4.04","trade":"-3.87","ind":"-3.44"},{"date":"2026.06.25","stock":"-1.17","trade":"-1.00","ind":"1.82"},{"date":"2026.06.24","stock":"-1.31","trade":"-1.03","ind":"1.24"},{"date":"2026.06.23","stock":"2.37","trade":"2.96","ind":"-3.17"},{"date":"2026.06.22","stock":"-1.48","trade":"-0.76","ind":"2.13"},{"date":"2026.06.18","stock":"0.08","trade":"1.76","ind":"0.94"}]
华兰生物,深证成指,生物制品指数
压力支撑
该股压力位为13.38元，支撑位为13.05元。
[{"text":"\u538b\u529b\u4f4d","value":"13.38","date":1784217600,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"13.05","date":1784217600,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前正处于反弹阶段，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：4.7资金面打败了56%的股票
主力控盘前10的股票
行业资金
生物制品行业， 近5日资金总体无进出。
更新时间：07月17日 20:30
| 机构今日流向(万元) | -2585.41 | 机构5日流向(万元) | 515.96 |
| 机构10日流向(万元) | 41.28 | 机构20日流向(万元) | 1728.64 |
机构持仓
2025-12-31 与 2025-06-30 相比，主力机构持仓量减少4419.4万股，其中基金净减仓74家，主力净减仓31家，请投资者中长期谨慎为宜。
截止2025-12-31，共253家主力机构（基金248家，券商1家，一般法人4家），持仓量总计68002.89万股，占流通A股43.22%
其中，基金持仓与2025-06-30相比：
增仓：49家 ，增持 1423.08万股
减仓：123家 ，减持 1214.09万股
新出现在主力名单中：62家 ，持有2602.3万股
从主力名单中消失：93家 ，原持有5830.71万股
其中，基金持仓与2025-06-30相比：
增仓：49家 ，增持 1423.08万股
减仓：123家 ，减持 1214.09万股
新出现在主力名单中：62家 ，持有2602.3万股
从主力名单中消失：93家 ，原持有5830.71万股
消息面诊股
诊断结果：5.9消息面打败了19%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 华兰生物：7月16日获融资买入1482.61万元
2026-07-17 - 华兰生物：7月15日获融资买入1418.75万元
2026-07-16 - 华兰生物：7月14日获融资买入948.03万元
2026-07-15 - 华兰生物：7月13日获融资买入770.39万元
2026-07-14 - 华兰生物：7月10日获融资买入1290.75万元
2026-07-13 - 河南3家药企上榜中国医药工业营收百强
2026-07-13 - 行业周报|生物制品指数跌-1.14%, 跑赢上证指
2026-07-10 - 2025年全国疫苗接种总剂次创新低，多位专家剖析背
2026-07-10 - 华兰生物：7月9日获融资买入707.14万元
2026-07-10 - 华兰生物：7月8日获融资买入928.60万元
2026-07-09
消息列表
| 一般消息 | 高管变动 | 因连续担任公司独立董事即将满六年 | 2026-04-20 |
| 一般消息 | 股东大会 | 年度股东大会 | 2026-03-28 |
| 利好 | 分红转增 | 10派5元(含税) | 2026-03-28 |
| 一般消息 | 募资投向 | 公司出售资产 | 2026-03-28 |
| 一般消息 | 募资投向 | 公司购买资产 | 2026-03-28 |
| 一般消息 | 重大事项 | 关联交易 | 2026-03-28 |
| 一般消息 | 重大事项 | 关联交易 | 2025-11-18 |
| 一般消息 | 高管变动 | 因个人原因 | 2025-11-17 |
| 一般消息 | 高管变动 | 因工作调动原因 | 2025-10-29 |
| 利好 | 分红转增 | 10派5元(含税) | 2025-08-28 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 2条 | 0条 | 2条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：6.4行业面打败了87%的股票
生物制品行业最新资金流向
近10日来该行业走势不明显，跑赢大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，跑赢大盘。
[{"date":"2026.07.17","price":"-5.40","value":"-7.01"},{"date":"2026.07.16","price":"-1.97","value":"0.36"},{"date":"2026.07.15","price":"-0.97","value":"2.67"},{"date":"2026.07.14","price":"2.77","value":"2.74"},{"date":"2026.07.13","price":"-3.48","value":"-1.36"},{"date":"2026.07.10","price":"-2.29","value":"3.33"},{"date":"2026.07.09","price":"3.07","value":"0.10"},{"date":"2026.07.08","price":"-1.87","value":"-1.54"},{"date":"2026.07.07","price":"-1.24","value":"-4.28"},{"date":"2026.07.06","price":"-1.16","value":"1.41"},{"date":"2026.07.03","price":"0.64","value":"1.88"},{"date":"2026.07.02","price":"-3.85","value":"-0.24"},{"date":"2026.07.01","price":"-0.53","value":"4.33"},{"date":"2026.06.30","price":"2.48","value":"-0.54"},{"date":"2026.06.29","price":"0.19","value":"7.43"},{"date":"2026.06.26","price":"-3.44","value":"-3.87"},{"date":"2026.06.25","price":"1.82","value":"-1.00"},{"date":"2026.06.24","price":"1.24","value":"-1.03"},{"date":"2026.06.23","price":"-3.17","value":"2.96"},{"date":"2026.06.22","price":"2.13","value":"-0.76"},{"date":"2026.06.18","price":"0.94","value":"1.76"}]
深证成指,生物制品行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 四环生物 | 24.68% | -4.19% | 5.7分 |
| 2 | 艾迪药业 | 22.20% | 7.26% | 6.6分 |
| 3 | 百普赛斯 | 19.71% | -4.45% | 5.6分 |
| 4 | 康辰药业 | 17.48% | 7.14% | 6.9分 |
| 5 | 君实生物 | 16.65% | -6.65% | 5.4分 |
| 6 | 赛升药业 | 15.71% | -3.08% | 4.9分 |
| 8 | 昊帆生物 | 13.60% | -9.66% | 5.5分 |
| 10 | 长春高新 | 13.07% | 4.29% | 5.4分 |
| 12 | 我武生物 | 13.03% | 0.93% | 5.7分 |
| 14 | 诺诚健华 | 11.15% | -10.95% | 5.4分 |
| 16 | 上海莱士 | 10.17% | 11.14% | 6.0分 |
| 18 | 双成药业 | 8.60% | -9.38% | 5.6分 |
| 20 | 诺唯赞 | 7.38% | -6.53% | 5.7分 |
| 22 | 安科生物 | 6.65% | -0.61% | 6.5分 |
| 24 | 博晖创新 | 5.84% | 3.52% | 5.4分 |
| 26 | 科兴制药 | 4.98% | -10.41% | 5.2分 |
| 28 | 西藏药业 | 4.08% | 0.71% | 6.0分 |
| 30 | 百克生物 | 3.58% | 0.27% | 5.5分 |
| 32 | 优宁维 | 3.28% | 0.83% | 5.6分 |
| 34 | 华兰生物 | 2.65% | 2.97% | 5.8分 |
| 36 | 金迪克 | 1.82% | -6.56% | 4.3分 |
| 38 | 华兰疫苗 | 1.70% | -0.89% | 5.5分 |
| 40 | - | 1.08% | -7.84% | 分 |
| 42 | 博雅生物 | -0.13% | 6.53% | 5.8分 |
| 44 | 康希诺 | -0.76% | -3.37% | 4.8分 |
| 46 | - | -5.29% | 7.65% | 分 |
| 48 | - | -6.18% | -18.63% | 分 |
| 50 | 东宝生物 | -8.04% | -4.37% | 5.1分 |
| 52 | 欧林生物 | -14.82% | -31.48% | 5.1分 |
| 54 | 赛伦生物 | -31.59% | -15.85% | 4.3分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2026-03-31 ]公司经营
盈利能力：较强，高于行业平均，两项指标的行业排名分别为 10/71 ， 37/71。
[{"date":"2026-03-31","value":"1.98","vol":"-6.01"},{"date":"2025-12-31","value":"8.05","vol":"-12.99"},{"date":"2025-09-30","value":"6.75","vol":"-10.09"},{"date":"2025-06-30","value":"4.32","vol":"-0.66"},{"date":"2025-03-31","value":"2.61","vol":"-0.34"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
1.98 | 8.05 | 6.75 | 4.32 | 2.61 |
| 行业(%) | -6.01 | -12.99 | -10.09 | -0.66 | -0.34 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"50.19","vol":"61.43"},{"date":"2025-12-31","value":"57.53","vol":"66.53"},{"date":"2025-09-30","value":"57.68","vol":"67.71"},{"date":"2025-06-30","value":"52.58","vol":"66.67"},{"date":"2025-03-31","value":"56.28","vol":"38.38"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
50.19 | 57.53 | 57.68 | 52.58 | 56.28 |
| 行业(%) | 61.43 | 66.53 | 67.71 | 66.67 | 38.38 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 41/71 ， 32/71。
[{"date":"2026-03-31","value":"-12.16","vol":"297.05"},{"date":"2025-12-31","value":"4.93","vol":"39.85"},{"date":"2025-09-30","value":"-3.20","vol":"45.81"},{"date":"2025-06-30","value":"8.80","vol":"6902.14"},{"date":"2025-03-31","value":"10.20","vol":"6125.11"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-12.16 | 4.93 | -3.20 | 8.80 | 10.20 |
| 行业(%) | 297.05 | 39.85 | 45.81 | 6902.14 | 6125.11 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"-26.44","vol":"74.22"},{"date":"2025-12-31","value":"-13.55","vol":"33.79"},{"date":"2025-09-30","value":"-15.07","vol":"45.67"},{"date":"2025-06-30","value":"17.19","vol":"5.21"},{"date":"2025-03-31","value":"19.62","vol":"-8.79"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-26.44 | -13.55 | -15.07 | 17.19 | 19.62 |
| 行业(%) | 74.22 | 33.79 | 45.67 | 5.21 | -8.79 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：一般，低于行业平均，两项指标的行业排名分别为 30/71 ， 36/71。
[{"date":"2026-03-31","value":"0.05","vol":"0.06"},{"date":"2025-12-31","value":"0.29","vol":"0.29"},{"date":"2025-09-30","value":"0.21","vol":"0.21"},{"date":"2025-06-30","value":"0.11","vol":"0.13"},{"date":"2025-03-31","value":"0.05","vol":"0.06"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.05 | 0.29 | 0.21 | 0.11 | 0.05 |
| 行业(次) | 0.06 | 0.29 | 0.21 | 0.13 | 0.06 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"0.16","vol":"0.29"},{"date":"2025-12-31","value":"0.90","vol":"1.29"},{"date":"2025-09-30","value":"0.66","vol":"0.90"},{"date":"2025-06-30","value":"0.39","vol":"0.55"},{"date":"2025-03-31","value":"0.18","vol":"0.25"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.16 | 0.90 | 0.66 | 0.39 | 0.18 |
| 行业(次) | 0.29 | 1.29 | 0.90 | 0.55 | 0.25 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2026-03-31","value":"-0.84","vol":"-78.67"},{"date":"2025-12-31","value":"35.14","vol":"12.85"},{"date":"2025-09-30","value":"13.93","vol":"0.21"},{"date":"2025-06-30","value":"23.25","vol":"-1377.65"},{"date":"2025-03-31","value":"1.63","vol":"-2083.82"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | -0.84 | 35.14 | 13.93 | 23.25 | 1.63 |
| 行业 | -78.67 | 12.85 | 0.21 | -1377.65 | -2083.82 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"0.70","vol":"1.74"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.80","vol":"1.55"},{"date":"2025-03-31","value":"","vol":"0.00"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.70 | - | 0.80 | - |
| 行业 | 0.00 | 1.74 | 0.00 | 1.55 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：较强，高于行业平均，两项指标的行业排名分别为 40/71 ， 35/71。
[{"date":"2026-03-31","value":"6.57","vol":"6.66"},{"date":"2025-12-31","value":"4.93","vol":"5.80"},{"date":"2025-09-30","value":"3.43","vol":"6.07"},{"date":"2025-06-30","value":"6.37","vol":"6.57"},{"date":"2025-03-31","value":"4.45","vol":"7.73"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 流动比率 |
6.57 | 4.93 | 3.43 | 6.37 | 4.45 |
| 行业 | 6.66 | 5.80 | 6.07 | 6.57 | 7.73 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"4.30","vol":"5.14"},{"date":"2025-12-31","value":"3.05","vol":"4.43"},{"date":"2025-09-30","value":"2.16","vol":"4.89"},{"date":"2025-06-30","value":"3.19","vol":"5.24"},{"date":"2025-03-31","value":"2.42","vol":"6.33"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 速动比率 |
4.30 | 3.05 | 2.16 | 3.19 | 2.42 |
| 行业 | 5.14 | 4.43 | 4.89 | 5.24 | 6.33 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：较强，高于行业平均，两项指标的行业排名分别为 37/71 ， 39/71。
[{"date":"2026-03-31","value":"9.46","vol":"28.78"},{"date":"2025-12-31","value":"12.26","vol":"28.75"},{"date":"2025-09-30","value":"18.55","vol":"28.02"},{"date":"2025-06-30","value":"10.07","vol":"26.19"},{"date":"2025-03-31","value":"14.82","vol":"26.65"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
9.46 | 12.26 | 18.55 | 10.07 | 14.82 |
| 行业(%) | 28.78 | 28.75 | 28.02 | 26.19 | 26.65 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"0.12","vol":"2.54"},{"date":"2025-12-31","value":"0.16","vol":"1.42"},{"date":"2025-09-30","value":"0.27","vol":"0.58"},{"date":"2025-06-30","value":"0.13","vol":"1.11"},{"date":"2025-03-31","value":"0.20","vol":"0.80"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.12 | 0.16 | 0.27 | 0.13 | 0.20 |
| 行业(%) | 2.54 | 1.42 | 0.58 | 1.11 | 0.80 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以增持为主，认为该股票有一定投资价值。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中原证券 | 2026-06-08 | 增持 | |
| 诚通证券 | 2026-04-29 | 增持 | |
| 中信证券 | 2026-04-28 | 买入 |
机构预测
机构预测该股2026年每股收益与前一年相同，长期投资价值一般。
[{"date":"2022","yellowRectValue":"10.76","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"14.82","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"10.88","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"9.40","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"10.24","blueLineValue":"0.56","type":"YC"}]